WHO naming stem · suffix · 27 listed names
-tidine
This page was written with AI.
Famotidine, cimetidine and ranitidine are -tidine names; this page lists all 27 that WHO gives, with the brands each is sold under.
histamine-H2-receptor antagonists, cimetidine derivatives
Where it sits in a name
WHO writes the stem as -tidine. So the letters tidine sit at the end of the name (…tidine).
All 27 names WHO lists under -tidine
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 4 of 27 names appear in these lists: 4 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 3 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- bisfentidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cimetidineUS brands: TAGAMET HB, TAGAMET (discontinued in FDA listings), TAGAMET HB 200 (discontinued in FDA listings)EU (central) brands: none found
- dalcotidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- donetidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ebrotidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etintidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- famotidineUS brands: PEPCID AC, FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK) (discontinued in FDA listings), FLUXID (discontinued in FDA listings), PEPCID (discontinued in FDA listings), PEPCID PRESERVATIVE FREE (discontinued in FDA listings), PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER (discontinued in FDA listings), PEPCID RPD (discontinued in FDA listings)in combination: PEPCID COMPLETE with calcium carbonate + hydroxide; DUEXIS (discontinued in FDA listings) with ibuprofenEU (central) brands: none found
- lafutidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lamtidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lavoltidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- loxtidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lupitidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mifentidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- niperotidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nizatidineEU (central) brands: none found
- osutidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oxmetidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pibutidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- quisultidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ramixotidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ranitidineUS brands: ZANTAC (discontinued in FDA listings), ZANTAC 150 (discontinued in FDA listings), ZANTAC 25 (discontinued in FDA listings), ZANTAC 300 (discontinued in FDA listings), ZANTAC 75 (discontinued in FDA listings), ZANTAC IN PLASTIC CONTAINER (discontinued in FDA listings)EU (central) brands: none found
- roxatidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sufotidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tiotidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tuvatidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- venritidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zaltidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Names with these letters that are not histamine-H2-receptor antagonists, cimetidine derivatives
WHO lists these 8 names under -tidine, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of -tidine does not apply.
- azacitidineWHO’s note: antineoplastic
- benzethidine
- furethidine
- guanethidine
- hexetidine
- hydroxypethidine
- pethidine
- propinetidine
Same group, without the stem
WHO also lists this name under -tidine: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. It belongs to the same group of substances as the group (a) names above, yet it does not carry -tidine, so the name alone does not reveal the group.
- metiamide
Decode another name
Decoded
lamtidine
Listed INNCarries the WHO stem -tidine
- -tidineend of the nameWHO lists it hereWHO definition: histamine-H2-receptor antagonists, cimetidine derivatives
“lamtidine” is an INN that WHO lists under -tidine in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -tidine (Part II B) and the 27 names (Part IV, group (a)), and the 8 not in accordance with it (group (b)) and 1 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.